RESUMO
AIMS: Kisangani is an area with intense malaria transmission and sulfadoxine-pyrimethamine resistance. Alternative antimalaria prophylaxis medication and protocols are needed, particularly with pregnant individuals. In this study, we compare the tolerance and effectiveness of mefloquine regimen as a split dose with a meal vs. sulfadoxine-pyrimethamine for the intermittent preventive treatment in pregnant individuals in Kisangani. METHODS: This study was conducted from 15 May to 30 November 2019 as a single-blind, randomized clinical trial comparing 2 regimens of intermittent preventive treatment during pregnancy. The first regimen consisted of 4 doses of sulfadoxine-pyrimethamine, and the second of 2 doses of mefloquine taken as a split dose with meal. RESULTS: The occurrence of major or minor side-effects among patients treated with mefloquine and those treated with sulfadoxine-pyrimethamine were not statistically significant (major side effects: Fisher exact = 0.5014; minor side effects: P = .0961). Intermittent preventive treatment using mefloquine significantly reduced the risk of placental malaria (risk ratio [RR]: 0.4315, 95% confidence interval [CI]: 0.2201-0.8460), maternal peripheral parasitaemia (RR: 0.4397, 95% CI: 0.2377-0.8132) and low birth weight (RR: 0.4708, 95% CI: 0.2455-0.9029). CONCLUSION: Splitting dose and intake with a meal increased mefloquine tolerability while keeping its efficacy higher compared to sulfadoxine-pyrimethamine. Intermittent preventive treatment during pregnancy using mefloquine reduces the risk of placental malaria, maternal peripheral parasitaemia and low birth weight, compared to sulfadoxine-pyrimethamine. Thus, mefloquine is a good alternative to intermittent preventive treatment in pregnancy.
Assuntos
Antimaláricos , Complicações Parasitárias na Gravidez , Antimaláricos/efeitos adversos , República Democrática do Congo/epidemiologia , Combinação de Medicamentos , Feminino , Humanos , Mefloquina/efeitos adversos , Placenta , Gravidez , Complicações Parasitárias na Gravidez/tratamento farmacológico , Complicações Parasitárias na Gravidez/prevenção & controle , Método Simples-CegoRESUMO
Background: In 2005, the Democratic Republic of the Congo (DRC) switched to artesunate/amodiaquine as the first-line antimalarial in response to increasing sulfadoxine/pyrimethamine resistance and adopted intermittent preventive treatment using sulfadoxine/pyrimethamine in pregnancy. Objectives: To determine the prevalence of molecular markers of sulfadoxine/pyrimethamine resistance in southwestern DRC 10 years after the new policy was instituted. Methods: From March 2014 to December 2015, blood samples were collected from symptomatic patients presenting to outpatient centres in urban and rural areas. A total of 2030 confirmed Plasmodium falciparum isolates were genotyped at codons associated with sulfadoxine/pyrimethamine resistance. Results: The prevalence of pfdhfr-N51I, C59R and S108N and pfdhps-A437G mutations was consistently high; the prevalence of the pfdhps-K540E mutation was low but increased since its first report in 2008 in the same region, reaching 17.6% by 2015. The pfdhps-A581G mutation increased from â¼4.5% in 2014 to â¼14.0% in 2015 at urban sites while in rural areas it remained low (â¼4.0%). The mutations pfdhfr-I164L and pfdhps-A613S were detected for the first time in DRC. Also, 11 (0.8%) isolates revealed the presence of the newly described pfdhps-I431V mutation. Combining pfdhfr and pfdhps alleles, quintuple and sextuple mutations were observed, with the emergence of septuple (IRNI/IAGEGA)- and octuple (IRNI/VAGKGS)-mutant genotypes. Conclusions: Intermittent preventive treatment using sulfadoxine/pyrimethamine during pregnancy remains warranted in southwestern DRC. However, the expansion of pfdhps-K540E mutation and emergence of mutants that cause higher levels of sulfadoxine/pyrimethamine resistance is concerning and may present a challenge for future preventive interventions in the country.
Assuntos
Antimaláricos/farmacologia , Resistência a Múltiplos Medicamentos/genética , Plasmodium falciparum/efeitos dos fármacos , Proteínas de Protozoários/genética , Pirimetamina/farmacologia , Sulfadoxina/farmacologia , Tetra-Hidrofolato Desidrogenase/genética , Adolescente , Adulto , Alelos , Instituições de Assistência Ambulatorial/estatística & dados numéricos , Criança , Pré-Escolar , República Democrática do Congo , Feminino , Genótipo , Humanos , Malária Falciparum/sangue , Malária Falciparum/tratamento farmacológico , Masculino , Mutação , Polimorfismo Genético , Prevalência , Adulto JovemRESUMO
INTRODUCTION: The infectious risk in the healthcare setting is potentially ubiquitous. Several infectious agents may be transmitted to healthcare professionals, most of which are carried by blood and body fluids. The aim of this study was to assess knowledge, attitudes and practices of healthcare workers in delivery rooms and operating theatres about standard precautions in healthcare settings in order to deduce the actions to be implemented to improve their security. MATERIALS AND METHODS: A descriptive cross-sectional survey was conducted in September 2011. A questionnaire was sent to 96 people using the direct interview technique. RESULTS: Only 20% of study subjects were familiar with the main bloodborne viruses (HBV, HCV and HIV). 67.8% of them considered that standard precautions must be applied only to women in labour and suspected HIV-positive patients. Almost all respondents (91.1%) had already been subject to at least one AES during the last 12 months. Respondents appeared to have a poor knowledge of the recommended actions following an AES. Recapping of needles after care is a practice reported by 55.6% of respondents. Routine use of protective barriers is unsatisfactory. CONCLUSION: The frequent failure of systematic application of standard precautions in healthcare settings by healthcare workers in the city of Isiro should lead the Ministry of Health to implement a process designed to increase awareness about standard precautions and improve the equipment necessary for strict compliance with these precautions.